Story perspectives

New Tripeptides Cut Psoriasis Severity by 50%

4/4/2025

47 8

Summary

Story summary

Groundbreaking research from the University of Birmingham and University of Naples Federico II has unveiled powerful tripeptides within the PEPITEM molecule that significantly curb immune cell activation in psoriasis. Remarkably, these peptides slashed disease severity by 50%, rivaling the effectiveness of Clobetasol Proprionate. This discovery paves the way for innovative psoriasis treatments with fewer side effects and wider implications for inflammatory diseases.

1 of 1

Story summary

Groundbreaking research from the University of Birmingham and University of Naples Federico II has unveiled powerful tripeptides within the PEPITEM molecule that significantly curb immune cell activation in psoriasis. Remarkably, these peptides slashed disease severity by 50%, rivaling the effectiveness of Clobetasol Proprionate. This discovery paves the way for innovative psoriasis treatments with fewer side effects and wider implications for inflammatory diseases.